South & Central America Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material (Porcine Gelatin and Bovine Gelatin), Product (Active Hemostats, Passive Hemostats, and Combination Hemostats), Application (General Surgery, Cardiac Surgery, Vascular Surgery, Orthopedic Surgery, Neuro & Spine Surgery, and Others), and End User (Hospital & Clinics, Ambulatory Surgery Centers, and Others)

BMIRE00029828 | Pages: 118 | Medical Device | Mar 2024 | Type: Regional | Status: Published
The South & Central America flowable hemostats market is expected to grow from US$ 40.12 million in 2022 to US$ 48.41 million by 2028. It is estimated to grow at a CAGR of 3.2% from 2022 to 2028.

Research and Development (R&D) Activities Leading to Product Innovations Fuel South & Central America Flowable Hemostats Market

Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon's (Johnson & Johnson Medical Device Companies) new product, "SURGIFLO Hemostatic Matrix." SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.

South & Central America Flowable Hemostats Market Overview

South and Central America include Brazil, Argentina, and the Rest of South and Central America. The market for flowable Hemostats in the region is expected to grow owing to the growing adoption of flowable hemostats, increasing number of surgical procedures, and growing emphasis on blood-loss management strategies during surgical procedures. In addition, the implementation of organic strategies by major market players is also boosting the product reach and awareness in the region, leading to considerable growth the of flowable hemostats market in South and Central America. The adoption of flowable hemostats in Brazil is attributed to favorable government policies, growing emphasis on blood loss management during surgical procedures, and awareness of the benefits offered by flowable hemostats. Additionally, lucrative government policies and market potential are attracting global as well as local players to launch their products in the country. For instance, in 2015, 3D-Matrix, one of the considerable players in the hemostats market obtained product approval for its PureStat hemostat to commercialize it in the Brazil market. Furthermore, the higher number of surgical procedures are also expected to fuel the growth of Brazil flowable hemostats market. For instance, according to data published by the Ministry of Health, Brazil, the number of elective surgeries grew by an estimated 49.2% from January 2019 to September 2019. Such growth in the number of surgeries is likely to drive the growth of the hemostats market by 2028.

South & Central America Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Flowable Hemostats Market Segmentation

The South & Central America flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the South & Central America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the South & Central America flowable hemostats market in 2022.

In terms of product, the South & Central America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the South & Central America flowable hemostats market in 2022.

Based on application, the South & Central America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the South & Central America flowable hemostats market in 2022.

Based on end user, the South & Central America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the South & Central America flowable hemostats market in 2022.

By country, the South & Central America flowable hemostats market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences are some of the leading companies operating in the South & Central America flowable hemostats market.
TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South & Central America Flowable Hemostats Market - By Material

1.3.2 South & Central America Flowable Hemostats Market - By Product

1.3.3 South & Central America Flowable Hemostats Market - By Application

1.3.4 South & Central America Flowable Hemostats Market - By End User

1.3.5 South & Central America Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Flowable Hemostats Market Landscape

4.1 Overview

4.2 South & Central America PEST Analysis

4.2.1 South & Central America PEST Analysis

4.3 South & Central America Experts Opinion

5. South & Central America Flowable Hemostats Market Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Number of Injuries and Surgical Procedures

5.1.2 Rising Geriatric Population

5.2 Market Restraints

5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies

5.3 Market Opportunities

5.3.1 Increasing Number of Hospitals and Surgical Centers

5.4 Future Trends

5.4.1 Research and Development (R&D) Activities Leading to Product Innovations

5.5 Impact Analysis

6. Flowable Hemostats Market - South & Central America Analysis

6.1 South & Central America Flowable Hemostats Market Revenue Forecast & Analysis

6.1.1 South & Central America Flowable Hemostats Market Revenue Forecast & Analysis

7. South & Central America Flowable Hemostats Market Analysis - By Material

7.1 Bovine Gelatin

7.1.1 Overview

7.1.2 Bovine Gelatin: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

7.2 Porcine Gelatin

7.2.1 Overview

7.2.2 Porcine Gelatin: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Flowable Hemostats Market- By Product

8.1 Overview

8.2 Combination Hemostat

8.2.1 Overview

8.2.2 Combination Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8.3 Passive Hemostat

8.3.1 Overview

8.3.2 Passive Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8.4 Active Hemostat

8.4.1 Overview

8.4.2 Active Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Flowable Hemostats Market- By Application

9.1 Overview

9.2 General Surgery

9.2.1 Overview

9.2.2 General Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9.3 Cardiac Surgery

9.3.1 Overview

9.3.2 Cardiac Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9.4 Vascular Surgery

9.4.1 Overview

9.4.2 Vascular Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9.5 Orthopedic Surgery

9.5.1 Overview

9.5.2 Orthopedic Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9.6 Neuro and Spine Surgery

9.6.1 Overview

9.6.2 Neuro and Spine Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Flowable Hemostats Market Analysis - By End User

10.1 Overview

10.2 South & Central America Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals and Clinics: South & Central America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

10.4 Ambulatory Surgery Centers

10.4.1 Overview

10.4.2 Ambulatory Surgery Centers: South & Central America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: South & Central America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. South & Central America Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

11.1 South & Central America Flowable Hemostats Market Revenue and Forecasts To 2028

11.1.2 South & Central America: Flowable Hemostats Market, by Country, 2021 & 2028 (%)

11.1.2.1 Brazil

11.1.2.1.1 Brazil: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)

11.1.2.1.2 Brazil: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)

11.1.2.1.3 Brazil: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)

11.1.2.1.4 Brazil: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)

11.1.2.1.5 Brazil: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

11.1.2.2 Argentina

11.1.2.2.1 Argentina: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)

11.1.2.2.2 Argentina: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)

11.1.2.2.3 Argentina: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)

11.1.2.2.4 Argentina: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)

11.1.2.2.5 Argentina: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

11.1.2.3 Rest of South & Central America

11.1.2.3.1 Rest of South & Central America: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)

11.1.2.3.2 Rest of South & Central America: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)

11.1.2.3.3 Rest of South & Central America: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)

11.1.2.3.4 Rest of South & Central America: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)

11.1.2.3.5 Rest of South & Central America: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. Flowable Hemostats Market-Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Baxter International Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Ethicon (Johnson & Johnson)

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Teleflex Incorporated

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 3-D Matrix Medical Technology

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Aegis Lifesciences

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 South & Central America Glossary of Terms

LIST OF TABLES

Table 1. Brazil: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)

Table 2. Brazil: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)

Table 3. Brazil: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)

Table 4. Brazil: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

Table 5. Argentina: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)

Table 6. Argentina: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)

Table 7. Argentina: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)

Table 8. Argentina: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

Table 9. Rest of South & Central America: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)

Table 10. Rest of South & Central America: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)

Table 11. Rest of South & Central America: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)

Table 12. Rest of South & Central America: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments in the Flowable Hemostats Market

Table 14. Inorganic Developments in the Flowable Hemostats Market

Table 15. South & Central America Glossary of Terms

LIST OF FIGURES

Figure 1. South & Central America Flowable Hemostats Market Segmentation

Figure 2. South & Central America Flowable Hemostats Market, By Country

Figure 3. South & Central America Flowable Hemostats Market Overview

Figure 4. Bovine Gelatin Holds Maximum Share in South & Central America Flowable Hemostats Market

Figure 5. South & Central America Flowable Hemostats Market, by Country (US$ Million)

Figure 6. South & Central America Flowable Hemostats Market, Market Attractiveness

Figure 7. South & Central America: PEST Analysis

Figure 8. South & Central America Experts Opinion

Figure 9. Impact Analysis

Figure 10. South & Central America Flowable Hemostats Market - Revenue Forecast and Analysis - 2020- 2028

Figure 11. South & Central America Flowable Hemostats market Share, by Material, 2021 and 2028 (%)

Figure 12. Bovine Gelatin: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 13. Porcine Gelatin: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 14. South & Central America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)

Figure 15. Combination Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 16. Passive Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 17. Active Hemostat: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 18. South & Central America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)

Figure 19. General Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 20. Cardiac Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 21. Vascular Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 22. Orthopedic Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 23. Neuro and Spine Surgery: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 24. Others: South & Central America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

Figure 25. Hospitals and Clinics: South & Central America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

Figure 26. Ambulatory Surgery Centers: South & Central America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

Figure 27. Others: South & Central America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

Figure 28. South & Central America Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 29. South & Central America: Flowable Hemostats Market, by Country, 2021 & 2028 (%)

Figure 30. Brazil: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)

Figure 31. Argentina: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)

Figure 32. Rest of South & Central America: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)

Figure 33. Growth Strategies in the Flowable Hemostats Market (%)

1. Baxter International Inc

2. Ethicon (Johnson & Johnson)

3. Pfizer Inc.

4. Teleflex Incorporated

5. 3-D Matrix Medical Technology

6. Aegis Lifesciences

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America flowable hemostats market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America flowable hemostats market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440